Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multi-center, Randomized, Pilot Trial to Evaluate the My Hematology Oncology Patient Experience (MYHOPE™) for Multiple Myeloma (MM) Digital Care Network in Patients With MM

NCT04730505 is registered in ClinicalTrials.gov with Celgene as lead sponsor.

NCT NCT04730505
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04730505 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multi-center, Randomized, Pilot Trial to Evaluate the My Hematology Oncology Patient Experience (MYHOPE™) for Multiple Myeloma (MM) Digital Care Network in Patients With MM
Lead sponsor
Celgene
Phase
Phase 1
Overall status
Terminated
Start date
February 4, 2021
Completion date
June 21, 2021
Enrollment
2 (actual)
Sites
34

Conditions

As the registry lists them; a condition with its own page is linked.

multiple myeloma